HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
11:59 pm TONIGHT!
Since August, 2007, if you invested in the market, you'd be down -24.3%. But a small group of Zacks investors has quietly gained +22.2%. They know where to find value stocks at just the right time. Don’t miss your chance. Deadline: 11:59 pm Saturday, July 31 -- TONIGHT >>
Quote:
Login Free Membership
Search:

Analyst Blog  

Upgrading Hanger Ortho to Buy

May 01, 2008 | Comments: 0
Recommended this article (2)
HGR
Print    Share

First quarter EPS doubled on lower variable interest rate expense. Sales grew 9.6%, driven by strong patient care center growth. Operating margin gained 40 basis points due to higher gross margins and lower sales, general and administrative (SG&A) expenses. Effective tax rate declined 160 basis points to 40%. Hanger Orthopedic Group, Inc. (HGR - Analyst Report) guided 2008 EPS higher by five cents to $0.75-$0.77.

The company produced better-than-expected first quarter results, helped by strong 26% growth in distribution and a lower variable interest rate on debt. The sales growth was due to a $5.5 million or 4.2% increase in same-center sales in patient care business, a $3.4 million or 25.7% increase in outside sales of the distribution segment, and a $4.9 million increase from acquired entities.

The increase in SG&A was due to acquisition-related expenses, investment in growth strategies, and higher merit salaries and fixed overhead expenses. Importantly, another Medicare fee increase of will help 2008 results.

We are raising our estimates on the out-performance, and our 2008 EPS estimate is in-line with the company's range, two cents above our prior estimate. We believe the company should trade in-line with comparables.

Our target moves to $16, or roughly 21x our expected 2008 EPS of $0.76, in-line with the industry 1.3x median P/E/G and comparables 1.5x 2008 P/E/G average. We are changing our rating to a Buy based upon valuation, strong fundamentals, and the company s industry leadership position.

Read the full analyst report on HGR.


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Free Stock Analysis From Zacks
  Includes Zacks Long-Term Recommendation and Target Price
Read/Post Comments (0) | Recommended this article (2)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 650,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Jul 31, 2010 13:31 pm ET
DJIA 10465.94  -1.22 -0.01%
NASD 2254.7  3.01 0.13%
S&P 500 1101.6  0.07 0.01%
Partner Center